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ABSTRACT: There is enormous interest toward vanilloid agonists of the pain receptor TRPV1 
in analgesic therapy, but the mechanisms of their sensory neuron-blocking effects at high or 
repeated doses are still a matter of debate. Our results have demonstrated that capsaicin and 
resiniferatoxin form nanomolar complexes with calmodulin, and competitively inhibit TRPV1–
calmodulin interaction. These interactions involve the protein recognition interface of 
calmodulin, which is responsible for all of the cell-regulatory calmodulin–protein interactions. 
These results draw attention to a previously unknown vanilloid target, which may contribute to 
the explanation of the paradoxical pain-modulating behaviour of these important pharmacons. 
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INTRODUCTION 
Vanilloid compounds (Figure 1 inset), such as capsaicin (CAP) and resiniferatoxin (RTX), have 
long been used as probes for sensory neuronal mechanisms,[1, 2] and have gained therapeutical 
applications.[3] CAP, the major pungent principle of hot chili peppers,[4] is administered 
topically (>5%) for purposes of pain relief.[5] RTX, an irritant component of Euphorbia 
resinifera,[6] also displays a prolonged analgesic effect at high local concentrations (up to 100 
μM),[7] and is currently undergoing clinical phase II investigations (NCT00804154). These 
molecules dose-dependently stimulate and subsequently defunctionalize a subset of primary 
afferent neurons (C and Aδ). Behind these paradoxically opposite effects, there is a cascade of 
pharmacological processes, in which transient receptor potential vanilloid 1 (TRPV1) plays a 
central role.[8] TRPV1 is expressed by the peripheral sensory neurons and is responsible for the 
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pain sensation caused by various physical and chemical stimuli, such as noxious heat, an 
elevated proton concentration, and endogenous and natural ligands, including vanilloid 
compounds.[9, 10] Upon stimulation, the receptor opens and Ca2+ ions enter the cells causing 
membrane depolarization and an action potential. The increased Ca2+ influx is an important 
orchestrator of the subsequent neuronal responses: sensitization, desensitization, long-term nerve 
inactivation, and neurotoxic effects at higher doses.[11] The operation of TRPV1, however, is 
tightly regulated by the cytosolic Ca2+ level,[11] and the neurons possess complex machinery 
with which to protect themselves against excessive Ca2+ influx.[12] In contrast, the existence of 
these mechanisms cannot prevent the vanilloid-induced impairment of the neuronal functions, 
and this paradoxical behaviour is the principle behind the analgesic applications of vanilloids. 
We hypothesized that, besides opening the TRPV1 channel, vanilloid ligands can directly perturb 
the cellular control over the Ca2+-induced signaling by interacting with a target responsible for 
the Ca2+ sensing and TRPV1 regulation. A number of routes have been suggested for the 
modulation of TRPV1, in which CaM, a universal Ca2+ sensor within the cells (Figure S1),[13] 
plays a crucial mediating role and can be considered as a hub protein that affects multiple 
cellular pathways. Phosphorylation on the cytosolic domain of TRPV1 by Ca2+/CaM-dependent 
kinase II[14] sensitizes the channel, while dephosphorylation of the vanilloid receptor by 
Ca2+/CaM-modulated calcineurin phosphatase causes desensitization.[15] Further, CaM can play 
an important role[16] in the desensitization of the receptor as its binding site on TRPV1 overlaps 
with the ATP-binding site[17] and the phosphorylation and the sensitization[14] of the molecule 
are therefore impaired. TRPV1 binds CaM at both the N-terminal ankyrin repeats[18] and the C-
terminal cytoplasmic domains.[16] It has been postulated that CaM can bridge the cytosolic 
domains of TRPV1,[19] causing a conformational change after channel opening. The affinity of 
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TRPV1 for capsaicin has been shown to be dependent on the ability of the channel to bind 
CaM.[20] There are mechanisms for the vanilloid-induced neuronal dysfunction that are 
independent of direct channel regulation: disrupted axonal transport[21] and downregulated 
TRPV1 expression,[22] where Ca2+ homeostasis and regulation also appear pivotal.[23] The 
above literature findings led us to test the direct vanilloid–CaM interactions at the molecular 
level, which could interfere with Ca2+ regulation, and hence with the TRPV1-mediated function 
of the sensory neurons. 
We show here that both CAP and RTX are nM ligands of CaM. A common high-affinity binding 
site was located for the vanilloids within the hydrophobic core of the Ca2+-stabilized EF-hand 
motifs, which is responsible for the generic protein recognition properties of CaM. 
Consequently, we observed the inhibitory effect of CAP and RTX on the TRPV1-CaM 
interaction.  
 
MATERIALS AND METHODS 
CaM expression and purification. Human CaM was cloned into the pET28a(+) vector by 
standard cloning procedures, and the His6-tagged protein was expressed and purified from an 
Escherichia coli BL21(λDE3) culture (Novagen). HisPurTM Ni-NTA Superflow Agarose 
(Thermo Scientific) or TALON® Metal Affinity Resin (Clontech) was used for affinity 
purification of the His6–CaM construct. The His-tag was removed by thrombin (Sigma-Aldrich) 
treatment and size exclusion chromatography (Superdex 75) was then used for the final 
purification step (ÄKTA FPLC). The protein was concentrated by using an Amicon Ultra 
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(Millipore) centrifugal device, lyophilized in 20 mM HEPES pH 7.0 and stored at -80 °C. 
Uniformly 13C- and 15N-labelled CaM was purchased from Creative Biolabs. 
Design of NMR experiments and signal assignment. The interactions of CaM with the vanilloid 
ligands CAP and RTX were investigated experimentally by using solution-phase biophysical 
methods, NMR spectroscopy and isothermal titration calorimetry (ITC). The rather low 
solubility of these natural pharmacons imposes certain technical limitations. In order to facilitate 
the solution-phase measurements, a literature solubilisation method was applied, including 
dissolution in methanol, dilution with water and lyophilisation.[24] As indicated by the NMR 
measurements carried out in the presence of an internal standard, the final solubilities in aqueous 
buffer at pH 7.0 and at 30 °C were 320 μM and 18 μM for CAP and RTX, respectively (Figure 
S2). The solubilized vanilloid ligands could be dissolved incrementally with the protein-
containing sample, and the concentration increase was feasible in a stepwise manner. At a CaM 
concentration of 60 μM, 15N-HSQC NMR titrations were possible whereby the protein could be 
saturated with the ligands, which appeared sufficient for the detection of any biologically 
relevant CaM–ligand interaction. 
15N-HSQC titrations for 15N/13C-labelled CaM. 15N-HSQC titration experiments were 
performed with [15N/13C]-CaM (60 μM). Reference 2D heteronuclear 15N-HSQC spectra were 
acquired for the ligand-free Ca2+-bound CaM. Since a sufficiently concentrated stock solution 
could not be prepared from CAP and RTX, ligands were added in a solid form (aliquoted and 
lyophilized from dilute solutions) to the protein sample. Six-nine separate titration points were 
obtained at different ligand concentrations. At the final titration point, the solution was saturated 
for the compound. For all the titration points, 15N-HSQC spectra were acquired with 256 
increments and the number of scans was 4. The line-broadening analysis was carried out by 
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using the 15N-HSQC spectra recorded at various ligand concentrations. The line-broadening 
values were calculated by using the formula 1 – I/I0,[25] where I is the signal intensity, and I0 is 
the intensity measured in the ligand-free state. 
Isothermal titration calorimetry. ITC experiments were carried out with a MicroCal VP-ITC 
microcalorimeter. Binding experiments for vanilloids were performed in 20 mM pH 7.0 HEPES 
buffer containing 30 mM CaCl2 at 35 °C. Because of their poor solubility, two types of titration 
were applied. First, the ligands were in the 1420-μl cell at a concentration of 25 μM and 15 μM, 
for CAP and RTX, respectively. In individual titrations, 15 μl of CaM solution was injected into 
the ligand solution from the computer-controlled microsyringe at intervals of 300 s. The 
concentration of CaM in the titration syringe was 146 or 237 μM. For CAP, CaM solution was 
placed in the cell at a concentration of 11 μM. In individual titrations, 15 μl of CAP solution was 
injected. The concentration of CAP in the titration syringe was 300 μM. Control experiments 
were performed by injecting CaM or CAP into the cell containing buffer with no interacting 
partner. Experimental data were fitted to the two independent binding sites model (adjustable 
parameters: n1, n2, KD1, KD2, ΔH1 and ΔH2) by using a non-linear least-squares procedure. The 
errors of fitting were estimated with jack-knife resampling.  
 
RESULTS AND DISCUSSION 
Ca2+-dependent CaM–vanilloid binding detected by 15N-HSQC titrations. After optimizing 
the NMR experiments with respect to the low solubility of the ligands (see supporting text), the 
15N-HSQC NMR titrations on CaM–Ca2+ samples resulted in marked changes in the spectra for 
both CAP and RTX (Figure 1). When the 15N-HSQC NMR titrations were repeated with Ca2+-
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free CaM (20 mM EGTA), no interaction was detected (Figure S3), indicating that the CaM–
vanilloid binding is Ca2+-dependent. For CAP, the chemical shift perturbations (CSPs) revealed a 
complex pattern (Figure 2a-c). Saturation of the CSPs was reached above 3.0 equivalents (Figure 
S6a,c), and the peaks could be classified into four categories according to their CSP behaviour: 
(i) peaks exhibiting no CSP; (ii) curved trajectory CSPs with partial ligand-dependent 
broadening (Figure 2a); (iii) residues undergoing slow/intermediate-exchange that displayed 
marked ligand-dependent broadening (Figure 2b); and (iv) linear trajectory CSPs in fast-
exchange (Figure 2c). These observations supported the occurrence of the CaM–CAP 
interaction, and suggested that CAP has multiple binding sites on CaM. The slow/intermediate-
exchange CSPs pointed to a high affinity (Kd < 1 μM) site for CAP, and/or to a slow ligand-
induced conformational rearrangement of the protein. The fast-exchange CSPs revealed a weaker 
(Kd > 1 μM) interaction. The turns of the CSPs appeared at around 1.0 equivalent, which 
indicated a ratio of 1:1 for strong binding, which was accompanied by a weak interaction at 
multiple sites. For RTX, the CSP saturation was reached at around 2.0 equivalents (Figures 2d,e 
and S6b,d), and there was no curved trajectory. Line broadening was a general feature for the 
residues, but some of the peaks did not gain measurable intensity after CSP saturation. These 
findings indicated that RTX has only one Kd < 1 μM binding mode. 
 
High-affinity and inhibitory binding of vanilloids to CaM detected by ITC. CSP data are not 
well suited for the quantitative estimation of affinity and stoichiometry.[26] Independent 
quantitative measurements of the thermodynamic properties of the interactions were carried out 
by means of ITC. For CAP, the ITC conditions could be optimized for both protein in the cell 
and ligand in the cell experimental set-ups. The protein titration with 11 μM CaM (Figures 3a 
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and S7) resulted in a two-stage enthalpogram supporting the presence of two separate binding 
events. Accordingly, the data were fitted by using a model with two independent binding sites: n1 
= 0.97 ± 0.003, n2 = 1.97 ± 0.005, KD1 = 280 ± 25.5 nM, KD2 = 1205 ± 86.8 nM, ΔH1 = 0.24 ± 
0.05 kcal mol-1, ΔH2 = -0.38 ± 0.03 kcal mol-1. The ligand titration with 25 μM CAP yielded the 
expected fractional stoichiometry relative to CaM, and a long tail passing one equivalent, 
because of the competition between the high- and low-affinity binding sites (Figure 3b). The 
non-linear regression of the two independent binding sites model was performed with variable 
protein concentration: n1 = 1.01 ± 0.006, n2 = 2.2 ± 0.05, KD1 = 184 ± 8.6 nM, KD2 = 1838 ± 
148.3 nM, ΔH1 = -0.93 ± 0.01 kcal mol-1, ΔH2 = -0.22 ± 0.01 kcal mol-1. It was safe to conclude 
that both titration set-ups captured the same binding events characteristic of the CAP–CaM 
interaction. ΔH1 displayed a difference of 1.17 kcal mol-1, which is an acceptable buffer- and 
initial concentration-dependent difference. For RTX, only the ligand titration with 15 μM RTX 
could be carried out, because of the limited solubility of RTX. The enthalpogram indicated a 
single binding site with the following properties (Figure 3c): n = 1.02 ± 0.003, KD = 802 ± 24.2 
nM, ΔH = -0.91 ± 0.004 kcal mol-1. With the Ca2+-free CaM, there was no ligand-dependent heat 
response in ITC for CAP and RTX, confirming that the CaM–vanilloid binding was Ca2+-
dependent. Further, the ligand binding did not affect the affinity of CaM toward Ca2+ (Figure 
S8).  
Having the nanomolar vanilloid – CaM bindings detected, we tested whether these compounds 
are capable of inhibiting direct TRPV1–CaM interaction. The C-terminal CaM-binding segment 
of TRPV1, 784-798 (TRPV1-CT, GRNWKNFALVPLLRD)[18] was synthesized and purified 
via standard peptide coupling methods. Our ITC measurements confirmed the literature finding, 
and the 1:1 complex of TRPV1-CT–CaM displayed a KD of 34.6 ± 2.2 nM (Figure 3d). 
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Repeating the measurement with CAP or RTX as inhibitors in the cell the apparent KD of 
TRPV1-CT shifted to 1804 ± 121.5 nM and 186 ± 10.5 nM for CAP and RTX, respectively 
(Figure 3d, 3e). The significant decrease in the apparent affinity of TRPV1-CT in presence of 
vanilloids indicated competitive inhibition. By using the Cheng-Prusoff formula with the KD 
results for the vanilloids and TRPV1-CT and an estimated low nanomolar intracellular 
concentration of the CaM-TRPV1 complex, the IC50 values were estimated as 0.69 μM and 1.98 
μM for CAP and RTX, respectively. The IC50 value of 0.69 μM is below the CAP concentrations 
normally utilized in therapy and in pharmacological experiments (>= 1 μM). For RTX, the IC50 
of 1.98 μM, is well above the RTX concentration normally applied in pharmacological 
experiments, but a magnitude below the therapeutical doses used in analgesic therapy. 
 
NMR-guided computational model for the high-affinity CaM – CAP complex. The 1:1 nM 
binding stage of CAP to CaM afforded the build-up of certain protein–ligand NOEs in the 13C-
filtered-3D-HSQC-NOESY spectra, and the 3D-15N-and 13C- NOESY-HSQC recordings were 
also successful (60 μM CaM and 300 μM CAP), though with limited spectral resolution and 
signal-to-noise. Nevertheless, the iterative signal assignment (see details in the Supporting 
Information) unambiguously revealed a total of 290 NOE interactions. The data suggested inter-
domain proximity within CaM including contacts between loop S38-Q41 and helix T117-A128, 
and between the N-terminal loop and the C-terminal helix. Cross-peaks from the methyl groups 
of the isopropyl moiety of CAP to the side-chain methyls of M124 and I125 could be assigned. 
Clear NOE contacts from the aromatic 2-H of the vanilloid moiety to the side-chain methyls of 
M71, M76 and M51 were observed, which determined the orientation of CAP. Further protein–
ligand NOEs were found pointing to apolar and aromatic side-chains, but these interactions could 
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not be unambiguously assigned. For the iterative NMR guided optimization (see details in the 
Supporting Information) of the CaM-CAP complex, the following restraints were used: (i) NOE-
derived protein distance restraints, (ii) NOE- and CSP-derived (Figure S7 and S8) protein–ligand 
distance restraints, (iii) secondary structure propensity score-derived (SSP, Figure S6)[27] 
backbone dihedral restraints, (iv) restraints to keep Ca2+ ions in the proximity of the 
corresponding charged groups, and (v) inter-strand H-bond restraints in the β-sheet segments. 
The solution-phase conformational pool of CaM–Ca2+ thoroughly sampled by the Bax and 
Vendruscolo groups (PDB code: 2K0E)[28, 29] was utilized to select the initial CaM structure, 
and CAP was manually docked into the assumed cavity already observable in the selected initial 
structure. It must be emphasized that the 542 structural restraints in total did not allow a 
refinement of a high-resolution geometry, but the sparse NMR restraints afforded the generation 
of a low-to-mid resolution model[30] capturing the main features of the CaM-CAP complex 
(Figure 4). The calculations yielded compact structures and the expected domain contacts, where 
the N- and C-terminal lobes of CaM formed the CAP binding site with CAP in an extended 
conformation. The results suggested that the vanilloid binding sub-site was formed by residues 
L32, N42, T44, E45, L48, M51, I52, V55, I63, F68, M71, M72, K75 and M76 at the N-terminal, 
and the isopropyl moiety was surrounded by residues F92, L105, M109, V121, M124, I125, 
F141 and M144 at the C-terminal. 
CONCLUSION 
We conclude that the vanilloid compounds studied are nM ligands of CaM and competitive 
inhibitors of the TRPV1–CaM interaction. The IC50 values calculated from the dissociation 
constants (low μM) indicate that the TRPV1 – CaM complex can be a relevant target for 
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vanilloids at the concentrations applied in the TRPV1-based analgesic therapy (well above 10 
μM). The NMR guided model calculations for the CaM–Ca2+–CAP complex resulted in a 
compact fold where the binding sites of CaM necessary for protein recognition are occupied, 
which points to the vanilloid ligands as competitive antagonists of CaM in general. In view of 
the central role of CaM in Ca2+ signalling, these results may contribute to the explanation of the 
mechanism of vanilloid-induced dose-dependent sensitization, desensitization and neuronal 
dysfunctions. 
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Appendix A. Supplementary data 
Additional supporting information may be found in the online version of this article at the 
publisher’s web site: 
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Figure 1. An overlay of the 1H-15N-HSQC spectra of CaM–Ca2+ (blue) and CaM–Ca2+–CAP 
(red) (a), CaM–Ca2+ (blue) and CaM–Ca2+–RTX (red) (b). The chemical sctructure of the 
vanilloid ligands are given in inset. 
Figure 2. Representative 15N-HSQC chemical shift perturbations upon titration with CAP (a-c) 
and RTX (d–e). The spectra were recorded for CAP at ligand equivalents of 0.0 (red), 0.36 
(orange), 0.72 (yellow), 1.08 (green), 1.43 (beige), 1.80 (coral), 2.15 (turquoise), 2.5 (blue), 3.2 
(pink), and 5.0 (purple). The spectra were recorded for RTX at ligand equivalents of 0.0 (red), 
0.34 (orange), 0.70 (yellow), 1.4 (green), 2.08 (beige), and 3.5 (pink). 
Figure 3. ITC titrations of 11 μM CaM with CAP (a), 25 μM CAP with CaM (b) and 15 μM 
RTX with CaM (c), 11 μM CaM with TRPV1-CT (d). Competitive ITC titrations of 11 μM CaM 
with TRPV1-CT as titrant, and CAP (e) and RTX (f) present in the cell as inhibitors at 
concentrations of 21 μM and 12.5 μM, respectively. The background-corrected binding 
isotherms (square) were fitted for the two independent binding sites model (solid lines).  
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Figure 4. NMR-guided computational model for the high-affinity CaM – CAP complex 
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